Promising Treatments Have Come Up Short In Addressing the Growing Burden of Calcium
Current Landscape of
Calcium Burden and Modification Tools
One of the reasons problematic calcium in cardiovascular disease has long been associated with worse clinical outcomes is that
existing solutions face common limitations.
Unable to Dilate
Don't Address Deep Calcium
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
Too bad our coronary technology is not yet approved in the United States. Good news is that we have initiated our U.S. FDA IDE study. Learn more about the Disrupt CAD III study on our clinical research portion of the website.